Skip to main content

International Aspects of Care: Europe

  • Chapter
  • First Online:
End of Life Care in Neurological Disease

Abstract

Across Europe there is much variation in both the neurology and palliative care services provided for people with progressive neurological disease. However there is increasing interest and collaboration in some areas. These initiatives are being developed across Europe, with improvement in the end of life care for patients and families.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. WHO. World Health Organisation Regional Office for Europe website. World Health Organisation; 2012 [cited Feb 8 2012]. Available from: http://www.euro.who.int/en/where-we-work.

  2. Europe Co. The Council of Europe website. 2012 [cited Feb 1 2012]. Available from: http://www.coe.int/lportal/web/coe-portal.

  3. EUROPA.EU. The European Union Portal. 2012 [cited Feb 1 2012]. Available from: http://europa.eu/about-eu/countries/index_it.htm.

  4. De Conno F, Blumhuber H, Rocafort J. The development of palliative medicine in Europe. In: Bruera E, Higginson I, Ripamonti C, Von Gunten C, editors. Textbook of palliative medicine. 1st ed. London: Hodder Arnold; 2009. p. 12–21.

    Google Scholar 

  5. Borasio GD, Voltz R. Palliative care in neurology. J Palliat Care. 2005;21(3):188–9.

    PubMed  Google Scholar 

  6. Saunders C, Walsh D, Smith M. Hospice care in motor neurone disease. In: Saunders C, Summers D, Teller N, editors. Hospice: the living idea. London: Edward Arnold; 1981. p. 126–55.

    Google Scholar 

  7. Voltz R, Bernat JL, Borasio GD, Maddocks I, Oliver D, Portenoy RK. (editors). Palliative care in neurology Oxford: Oxford University Press; 2004.

    Google Scholar 

  8. Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology. 1993;43(7):1316–22.

    Article  PubMed  CAS  Google Scholar 

  9. Clark D. Cicely Saunders. Founder of the hospice movement. Selected letters 1959–1999. Oxford: Oxford University Press; 2002.

    Google Scholar 

  10. Norris FH, Smith RA, Denys EH. Motor neurone disease: towards better care. Br Med J (Clin Res Ed). 1985;291(6490):259–62.

    Article  CAS  Google Scholar 

  11. O’Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. BMJ. 1992;304(6825):471–3.

    Article  PubMed  Google Scholar 

  12. Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248(7):612–6.

    Article  PubMed  CAS  Google Scholar 

  13. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311–23.

    Article  PubMed  CAS  Google Scholar 

  14. Voltz R, Borasio GD. Palliative therapy in the terminal stage of neurological disease. J Neurol. 1997;244 Suppl 4:S2–10.

    Article  PubMed  Google Scholar 

  15. Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77(8):948–50.

    Article  PubMed  CAS  Google Scholar 

  16. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effects of a multidisciplinary ALS clinic on survival. J Neurol Neurosurg Psychiatry. 2003;74:1258–61.

    Article  PubMed  CAS  Google Scholar 

  17. Golla H, Galushko M, Pfaff H, Voltz R. Unmet needs of severely affected multiple sclerosis patients: the health professionals’ view. Palliat Med. 2011;26(2):139–51.

    Article  PubMed  Google Scholar 

  18. Edmonds P, Vivat B, Burman R, Silber E, Higginson IJ. Loss and change: experiences of people severely affected by multiple sclerosis. Palliat Med. 2007;21(2):101–7.

    Article  PubMed  Google Scholar 

  19. Higginson IJ, Hart S, Silber E, Burman R, Edmonds P. Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliat Care. 2006;22(3):158–65.

    PubMed  Google Scholar 

  20. Edmonds P, Hart S, Wei G, Vivat B, Burman R, Silber E. Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service. Mult Scler. 2010;16(5):627–36.

    Article  PubMed  Google Scholar 

  21. Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM. Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manage. 2009;38(6):816–26.

    Article  PubMed  Google Scholar 

  22. Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage. 2006;32(5):462–9.

    Article  PubMed  Google Scholar 

  23. Lee MA, Walker RW, Hildreth AJ, Prentice WM. Individualized assessment of quality of life in idiopathic Parkinson’s disease. Mov Disord. 2006;21(11):1929–34.

    Article  PubMed  Google Scholar 

  24. Lee MA, Prentice WM, Hildreth AJ, Walker RW. Measuring symptom load in Idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2007;13(5):284–9.

    Article  PubMed  CAS  Google Scholar 

  25. EAPC. People with neurological disease. 2012 [cited Feb 8 2012]. Available from: http://www.eapcnet.eu/Themes/Specificgroups/Peoplewithneurologicaldisease/Guidelinescurriculumtaskforce.aspx.

  26. NHS. Improving end of life care in neurological disease. A framework for implementation. 2010 [cited Feb 8 2012]. Available from: http://www.endoflifecareforadults.nhs.uk/publications/end-of-life-care-in-long-term-neurological-conditions-a-framework.

  27. Law 38,15.3.10. Republic of Italy: Disposizioni per garantire l’accesso alle cure palliative ed alla terapia del dolore. 2010. Access at: http://www.parlamento.it/parlam/leggi/10038l.htm.

  28. Defanti CA. Study Group of Bioethics and Palliative Care in Neurology: program document. Neurol Sci. 2000;21(5):261–71.

    Article  PubMed  CAS  Google Scholar 

  29. Causarano R. Le cure palliative in neurologia: come, dove e quando. Neurol Sci. 2005;26:S127–31.

    Google Scholar 

  30. Defanti CA. Come muore il malato neurologico? Neurol Sci. 2005;26:S109–13.

    Google Scholar 

  31. Bonito V, Caraceni A, Borghi L, Marcello N, Mori M, Porteri C, et al. The clinical and ethical appropriateness of sedation in palliative neurological treatments. Neurol Sci. 2005;26(5):370–85.

    Article  PubMed  CAS  Google Scholar 

  32. Bonito V. Le dichiarazione anticipate in neurologia. Neurol Sci. 2005;26:S121–6.

    Article  Google Scholar 

  33. Bonito V, Primavera A, Borghi L, Mori M, Defanti CA. The discontinuation of life support measures in patients in a permanent vegetative state. Neurol Sci. 2002;23(3):131–9.

    Article  PubMed  CAS  Google Scholar 

  34. Congedo M, Causarano RI, Alberti F, Bonito V, Borghi L, Colombi L, et al. Ethical issues in end of life treatments for patients with dementia. Eur J Neurol. 2010;17(6):774–9.

    Article  PubMed  CAS  Google Scholar 

  35. Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59(1):99–103.

    Article  PubMed  CAS  Google Scholar 

  36. Veronese S, Oliver D, editors. Developing and evaluating a specialist palliative care service for people with neurodegenerative disorders. An application of the MRC framework for the design and the evaluation of complex interventions. In: 12th conference of the European Association for Palliative Care, Lisbon, 2011.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone Veronese .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Veronese, S. (2013). International Aspects of Care: Europe. In: Oliver, D. (eds) End of Life Care in Neurological Disease. Springer, London. https://doi.org/10.1007/978-0-85729-682-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-682-5_12

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-681-8

  • Online ISBN: 978-0-85729-682-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics